Olema Pharmaceuticals (OLMA) surges after Roche's breast cancer data, but caution is urged as key clinical results are ...

During last week's 20th Birthday Party-themed episode, Tom Bergeron made his guest judge debut while four couples earned solo ...

Vertex Pharmaceuticals continues to generate most of its revenue from its cystic fibrosis (CF) franchise. The company's ...

The domestic equity markets opened lower, with Nifty 50 down 0.32% and BSE Sensex down 0.33%. Analysts suggest that despite ...

Experts predict short-term volatility due to global factors, though domestic fundamentals suggest potential medium-term gains ...

Merck & Co. agreed to acquire Cidara Therapeutics Inc., a biotech company developing a flu treatment, as part of its ongoing ...

Australia on Friday blocked a A$672 million ($433 million) buyout offer for Mayne Pharma from U.S. drugmaker Cosette Pharmaceuticals, citing national interest.

Tarsus Pharmaceuticals, Inc. upgraded to Strong Buy; Xdemvy's rapid US growth and unique market lead highlight big upside.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the best gene-editing stocks to buy according to hedge funds.

Investing personality Jim Cramer recently called Recursion Pharmaceuticals a meme stock. The facts don't back up that ...

Shares in Agios Pharmaceuticals (NASDAQ: AGIO) crashed by 50% by noontime today. The move comes as the market digests a mixed set of topline results from its Phase 3 trial (RISE UP) of its sickle cell ...

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is one of the Hottest Small Cap Stocks to Buy Now. On November 11, Andy Hsieh from ...